Medicine composition for treating congestive heart failure and application thereof
A technology of heart failure and composition, which is applied in the field of pharmaceutical composition for the treatment of congestive heart failure, can solve the problems of side effects of western medicine, no obvious improvement of clinical symptoms, long-term curative effect needs further verification, etc., and achieves less toxic and side effects and good clinical Application prospects and the effect of reducing the mortality rate of heart failure
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0012] The preparation of embodiment 1 Chinese medicine extract
[0013] Weigh 1.2kg of mouse ear, 1.8kg of black soybean, 0.6kg of tortoise flower, 3.0kg of Niu Dali, 0.6kg of spinach seed, 1.5kg of daylily root, 1.2kg of silver bud, 1.5kg of dry lotus leaf and 1.8kg of Chaotian jar, Combine and pulverize; then add water to the above-mentioned granular medicinal materials to cover the surface of the medicine, soak for 0.5-1h, then remove and place in the extraction device, add water and decoct 3 times, add 135L of water for the first time, boil with high heat and simmer for 2 hours, and decoct for the second time Add 120L of water for the first time, boil with strong fire and simmer for 1.5h, add 120L of water for the third time, boil with strong fire and simmer for 1.5h, combine the decoction, filter, and concentrate the filtrate under reduced pressure at 0.08MPa to a relative density of 1.10 (65°C test), add 95% ethanol to make the volume alcohol content reach about 75%, st...
Embodiment 2
[0014] Embodiment 2 Chinese medicine extract is to the influence test of isoproterenol congestive heart failure rat model
[0015] 40 clean-grade male SD rats, 8 weeks old, after one week of adaptive feeding, 8 were randomly selected as blank controls, and other rats were subcutaneously injected with isoproterenol (ISO, 170mg / kg, divided into 2 times, with an interval of 24h). ) for modeling, and blank control rats were subcutaneously injected with 0.25 ml of normal saline. After 6 weeks of modeling, color ultrasound monitor was used to measure relevant indicators in two-dimensional imaging mode in the left ventricular short-axis view at the papillary muscle level, and the measured values were the average of 5 cardiac cycles. Modeling was successful when the left ventricular ejection fraction (LVEF) was less than or equal to 45%. 24 successful model rats were randomly divided into model control group, high-dose and low-dose Chinese medicine groups, 8 rats in each group. Af...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com